Stock MSLP MUSCLEPHARM CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials MusclePharm Corporation

Equities

MSLP

US6273352012

Investment Holding Companies

Market Closed - OTC Markets
Other stock markets
 03:28:56 2024-04-03 pm EDT 		5-day change 1st Jan Change
0.000001 USD -99.92% Intraday chart for MusclePharm Corporation -.--% -.--%
2023 Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation CI
2023 FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q). CI

Valuation

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Capitalization 1 24.21 9.523 8.578 7.89 6.776 13.35
Enterprise Value (EV) 1 38.75 28.62 26.99 17.69 17.21 29.28
P/E ratio -6.76 x -0.82 x -0.78 x -0.26 x 2.55 x -1.03 x
Yield - - - - - -
Capitalization / Revenue 0.18 x 0.09 x 0.1 x 0.1 x 0.11 x 0.27 x
EV / Revenue 0.29 x 0.28 x 0.31 x 0.22 x 0.27 x 0.59 x
EV / EBITDA 69.8 x -14.5 x -3.86 x -1.22 x 5.32 x -3.41 x
EV / FCF -1.95 x 45.6 x 2.81 x -15.8 x -2.22 x -11.4 x
FCF Yield -51.3% 2.19% 35.5% -6.34% -45.1% -8.81%
Price to Book -5.06 x -0.76 x -0.3 x -0.28 x -0.28 x -0.41 x
Nbr of stocks (in thousands) 13,835 14,651 15,315 32,875 33,217 33,386
Reference price 2 1.750 0.6500 0.5601 0.2400 0.2040 0.4000
Announcement Date 3/15/17 4/2/18 8/25/20 8/25/20 3/29/21 4/15/22
1USD in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net sales 1 132.5 102.2 88.11 79.67 64.44 50.04
EBITDA 1 0.555 -1.972 -6.983 -14.45 3.235 -8.582
EBIT 1 -1.572 -3.432 -7.832 -15.11 2.77 -8.913
Operating Margin -1.19% -3.36% -8.89% -18.96% 4.3% -17.81%
Earnings before Tax (EBT) 1 -3.159 -10.83 -10.66 -18.84 3.166 -12.87
Net income 1 -3.477 -10.97 -10.76 -18.93 3.185 -12.87
Net margin -2.62% -10.74% -12.21% -23.76% 4.94% -25.71%
EPS 2 -0.2587 -0.7907 -0.7159 -0.9244 0.0800 -0.3900
Free Cash Flow 1 -19.86 0.6279 9.587 -1.122 -7.766 -2.579
FCF margin -14.99% 0.61% 10.88% -1.41% -12.05% -5.15%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/15/17 4/2/18 8/25/20 8/25/20 3/29/21 4/15/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2016 2017 2018 2019 2020 2021
Net Debt 1 14.5 19.1 18.4 9.8 10.4 15.9
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 26.19 x -9.685 x -2.636 x -0.6785 x 3.225 x -1.856 x
Free Cash Flow 1 -19.9 0.63 9.59 -1.12 -7.77 -2.58
ROE (net income / shareholders' equity) 46.5% 126% 52.8% 67.4% -12.2% 45.5%
ROA (Net income/ Total Assets) -2.01% -6.32% -16.8% -48.2% 12.6% -46%
Assets 1 173.2 173.7 64.19 39.23 25.33 27.96
Book Value Per Share 2 -0.3500 -0.8600 -1.870 -0.8500 -0.7400 -0.9600
Cash Flow per Share 2 0.3500 0.4300 0.1500 0.0500 0.0600 0.0400
Capex 1 0.51 0.04 0.13 0.01 0 0
Capex / Sales 0.38% 0.04% 0.15% 0.02% 0.01% 0%
Announcement Date 3/15/17 4/2/18 8/25/20 8/25/20 3/29/21 4/15/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Shell Companies

1st Jan change Capi.
MUSCLEPHARM CORPORATION Stock MusclePharm Corporation
-.--% 33
TRUMP MEDIA & TECHNOLOGY GROUP CORP. Stock Trump Media & Technology Group Corp.
+158.06% 6.17B
SCREAMING EAGLE ACQUISITION CORP. Stock Screaming Eagle Acquisition Corp.
+0.47% 998M
CHURCHILL CAPITAL CORP VII Stock Churchill Capital Corp VII
+2.10% 982M
APPLE ISPORTS GROUP, INC. Stock Apple iSports Group, Inc.
+41.91% 872M
PERELLA WEINBERG PARTNERS Stock Perella Weinberg Partners
+22.89% 803M
ARES ACQUISITION CORPORATION II Stock Ares Acquisition Corporation II
+1.63% 663M
E7 GROUP Stock E7 Group
-1.80% 596M
DA ZHONG TRADING GROUP HOLDING COMPANY Stock Da Zhong Trading Group Holding Company
-.--% 600M
ALTC ACQUISITION CORP. Stock AltC Acquisition Corp.
+32.01% 601M
Shell Companies
  1. Stock Market
  2. Equities
  3. MSLP Stock
  4. Financials MusclePharm Corporation